5 Health Services Stocks Nudging The Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 12 points (0.1%) at 14,943 as of Thursday, Sept. 5, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,432 issues advancing vs. 1,453 declining with 120 unchanged.

The Health Services industry currently sits up 0.4% versus the S&P 500, which is up 0.2%. Top gainers within the industry include MiMedx Group ( MDXG), up 20.6%, WellCare Health Plans ( WCG), up 3.5%, Mindray Medical International ( MR), up 2.5%, DaVita HealthCare Partners ( DVA), up 1.9% and ResMed ( RMD), up 1.8%. A company within the industry that fell today was Smith & Nephew ( SNN), up 0.7%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. HCA Holdings ( HCA) is one of the companies pushing the Health Services industry higher today. As of noon trading, HCA Holdings is up $0.27 (0.7%) to $38.78 on heavy volume. Thus far, 2.6 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $38.44-$38.84 after having opened the day at $38.44 as compared to the previous trading day's close of $38.51.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $17.3 billion and is part of the health care sector. Shares are up 27.6% year to date as of the close of trading on Wednesday. Currently there are 13 analysts that rate HCA Holdings a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates HCA Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow, poor profit margins and feeble growth in its earnings per share. Get the full HCA Holdings Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Boston Scientific ( BSX) is up $0.36 (3.3%) to $11.29 on average volume. Thus far, 8.8 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 15.4 million shares. The stock has ranged in price between $10.95-$11.29 after having opened the day at $10.95 as compared to the previous trading day's close of $10.93.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $14.6 billion and is part of the health care sector. Shares are up 90.8% year to date as of the close of trading on Wednesday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, solid stock price performance, expanding profit margins, impressive record of earnings per share growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Boston Scientific Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Aetna ( AET) is up $0.73 (1.1%) to $65.04 on light volume. Thus far, 831,241 shares of Aetna exchanged hands as compared to its average daily volume of 2.6 million shares. The stock has ranged in price between $64.13-$65.36 after having opened the day at $64.21 as compared to the previous trading day's close of $64.31.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $23.7 billion and is part of the health care sector. Shares are up 38.9% year to date as of the close of trading on Wednesday. Currently there are 11 analysts that rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, attractive valuation levels and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Aetna Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Express Scripts ( ESRX) is up $0.34 (0.5%) to $64.90 on light volume. Thus far, 834,154 shares of Express Scripts exchanged hands as compared to its average daily volume of 3.9 million shares. The stock has ranged in price between $64.24-$65.08 after having opened the day at $64.33 as compared to the previous trading day's close of $64.56.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $52.5 billion and is part of the health care sector. Shares are up 19.4% year to date as of the close of trading on Wednesday. Currently there are 12 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Express Scripts Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Medtronic ( MDT) is up $0.33 (0.6%) to $53.53 on average volume. Thus far, 2.3 million shares of Medtronic exchanged hands as compared to its average daily volume of 4.9 million shares. The stock has ranged in price between $53.22-$53.56 after having opened the day at $53.27 as compared to the previous trading day's close of $53.20.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $52.5 billion and is part of the health care sector. Shares are up 29.7% year to date as of the close of trading on Wednesday. Currently there are 6 analysts that rate Medtronic a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, increase in net income and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Medtronic Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)